|
|
|
|
|
21.04.26 - 07:25
|
TUI-Chef sieht keinen Kerosin-Mangel (Der Aktionaer)
|
|
|
Am Wochenende gelang es den beiden TUI-Kreuzfahrtschiffen, die zuvor mehrere Wochen im Persischen Golf feststeckten, die Straße von Hormus zu passieren. Doch aktuell sorgen sich Marktteilnehmer um einen möglichen Engpass beim Kerosin. Doch aus Sicht des Vorstandschefs des Reisekonzerns TUI, Sebastian Ebel, besteht gegenwärtig kein Kerosin-Mangel....
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
21.04.26 - 07:12
|
Business Finland grants significant support to SSAB′s Sustainable World through Steels research and development program (Cision)
|
|
|
Business Finland, a Finnish public innovation funding organization, has granted SSAB EUR 20 million in funding for a new Sustainable World through Steels research and development program, aimed at the transition to fossil‑free steel production and the development of low‑carbon products in collaboration with customers.
[image]
SSAB has been selected as one of Business Finland's new leading companies in the challenge competition launched in spring 2025. With funding from Business Finland, SSAB will initiate a five‑year research and development program titled Sustainable World through Steels....
|
|
|
|
|
|
|
21.04.26 - 07:06
|
Interim report jan-mar 2026: Continued growth (Cision)
|
|
|
· Rental income increased 10 percent to SEK 1,150 million (1,045).
· Operating surplus increased 9 percent to SEK 800 million (731).
· Income from property management increased 12 percent to SEK 520 million (463).
· Profit for the period amounted to SEK 548 million (431), corresponding to earnings per share of SEK 1.78 (1.40).
Ulrika Hallengren, CEO of Wihlborgs, comments on the first quarter:
- Wihlborgs posted continued growth in the first quarter of 2026. Rental income increased 10 percent to SEK 1,150 million and for the fourth consecutive quarter sets another record....
|
|
|
|
|
|
|
21.04.26 - 07:03
|
FDA accepts application for Roche′s Gazyva/Gazyvaro for the treatment of the most common form of lupus (GlobeNewswire EN)
|
|
|
Basel, 21 April 2026 - Roche (SIX: RO, ROP; OTCQX: RHHBY) announced today that the US Food and Drug Administration (FDA) has accepted the company's supplemental Biologics License Application (sBLA) for Gazyva®/Gazyvaro® (obinutuzumab) for the treatment of systemic lupus erythematosus (SLE). The filing acceptance is based on positive results from the phase III ALLEGORY study, which demonstrated a statistically significant and clinically meaningful benefit in the primary endpoint of SLE Responder Index 4 (SRI-4) at 52 weeks – a measure that assesses changes in disease severity, symptoms and physical condition.2 The FDA is expected to make a decision on an approval by December 2026. Gazyva/Gazyvaro is already approved for adults with lupus nephritis in the US and EU....
|
|
|
21.04.26 - 07:03
|
SIKA ERWEITERT AKTIVITÄTEN IN ZENTRALASIEN MIT NEUER LÄNDERGESELLSCHAFT IN KIRGISISTAN (GlobeNewswire)
|
|
|
SIKA ERWEITERT AKTIVITÄTEN IN ZENTRALASIEN MIT NEUER LÄNDERGESELLSCHAFT IN KIRGISISTAN Sika stärkt die Position in Zentralasien mit der Gründung einer neuen Ländergesellschaft in Kirgisistan. Mit diesem Schritt baut das Unternehmen sein globales Netzwerk auf 103 Ländergesellschaften aus und unterstreicht die strategisch Bedeutung der dynamisch wachsenden Region. Die neue Tochtergesellschaft mit Sitz in Bischkek erhöht die Kundennähe und schafft die Grundlage für einen besseren Marktzugang in einem wirtschaftlich attraktiven Umfeld.Kirgisistan zählt zu den wachstumsstarken Volkswirtschaften Zentralasiens. Für den Zeitraum 2026 bis 2030 gehen Prognosen von einem durchschnittlichen Wachstum des Bruttoinlandprodukts von rund 7% pro Jahr aus. Als wichtige Wachstumstreiber im Bausektor gelten industrielle Bauvorhaben sowie Investitionen in Infrastruktur- und Energieprojekte. Diese werden massgeblich durch Programme internationaler Finanzinstitutionen – darunter die Weltbank – unterstützt und sor...
|
|
|
21.04.26 - 07:03
|
SIKA EXPANDS ITS ACTIVITIES IN CENTRAL ASIA WITH A NEW NATIONAL SUBSIDIARY IN KYRGYZSTAN (GlobeNewswire EN)
|
|
|
SIKA EXPANDS ITS ACTIVITIES IN CENTRAL ASIA WITH A NEW NATIONAL SUBSIDIARY IN KYRGYZSTAN Sika is strengthening its position in Central Asia by establishing a new national subsidiary in Kyrgyzstan. With this step, the company is expanding its global network to 103 national subsidiaries and underscoring the strategic significance of the dynamically growing region. The new subsidiary in Bishkek will increase customer proximity and create the basis for better market access in an attractive economic environment.Kyrgyzstan is one of the fastest-growing economies in Central Asia. Forecasts of average annual GDP growth are around 7% for the 2026-2030 period. Key growth drivers in the construction industry include industrial construction projects and investments in infrastructure and energy projects. These receive significant support from programs of international financial institutions – including the World Bank – and provide reliable demand momentum in the construction industry....
|
|
Alle News zu Europa 5998.7445 0.0% (E.St.50 Kurs)
Börsentreff auf Facebook |
Börsentreff auf X |
Börsentreff auf Instagram
